Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
This review evaluates the current evidence on combination therapies involving SGLT2is, GLP-1RAs, and nsMRAs in type 1 and type 2 diabetes, thereby focusing on treatments that in type 2 diabetes have shown cardio-renal protection, while exploring future research directions
The bottom line: With appropriate monitoring (especially in patients with active suicidal ideation or severe eating disorders), GLP-1s appear safe from a psychiatric standpoint
Nisar, T
A.Al-JuhaimiF
US$ 22.74
US$ 29.16
US$ 26.96
US$ 20.74
US$ 24.33
US$ 24.35
US$ 29.39
US$ 23.76
